An elderly woman undergoing treatment for organizing pneumonia and Graves\'s disease complained of severe headache after a reduction of her oral prednisolone dose (5 mg/day to 2.5 mg/day). Although her headache resolved spontaneously, it recurred with severe ophthalmalgia and she showed bloodshot eyes. Enhanced MRI revealed a thickened dura mater with a contrast effect ([Picture A and C](#g001){ref-type="fig"}: coronal, [Picture B](#g001){ref-type="fig"}: sagittal), leading to a diagnosis of hypertrophic pachymeningitis. The patient was positive for myeloperoxidase anti-neutrophil cytoplasmic antibodies and her immunoglobulin G4 level was elevated. Moderate scleritis was ophthalmologically evident ([Picture D](#g001){ref-type="fig"}). Intravenous methylprednisolone (500 mg for 3 days) followed by oral prednisolone (30 mg/day) improved her headache, eye pain, and MRI findings.
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The typical symptoms of hypertrophic pachymeningitis include headache with or without intracranial neurologic manifestations such as cranial neuropathy and cerebellar dysfunction ([@B1]). Despite the rarity, this disease combination should be kept in mind when we encounter patients with headache and eye pain ([@B2]).
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